Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05591859 · ClinicalTrials.gov registry record · NA
Restoration Anatomic Acetabular Shell Revision Study
A NA study of Hip Osteoarthritis and Hip Arthropathy, sponsored by Stryker Orthopaedics.
- Recruiting
- Registry status
- NA
- Development phase
- 56
- Enrollment target
- 1
- Study location
NCT05591859: Recruiting NA study of Hip Osteoarthritis and Hip Arthropathy, sponsored by Stryker Orthopaedics.
NCT05591859 is a NA study of Hip Osteoarthritis and Hip Arthropathy that is actively recruiting participants, run by Stryker Orthopaedics. The registered enrollment target is 56 participants, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05591859, a NA study of Hip Osteoarthritis and Hip Arthropathy, is actively recruiting participants, sponsored by Stryker Orthopaedics.
- RECRUITING
- Registry status
- NA
- Development phase
- 56 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjects who meet the eligibility criteria.
Conditions Studied
Interventions
- DEVICE Restoration Anatomic Acetabular Shell
Study Locations (1)
Colorado
- Regents of the University of Colorado - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2024-03-02 |
| Est. Completion | 2036-03-01 |
| Phase | NA |
What NCT05591859 shows while recruiting
NCT05591859 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 56 participants, a relatively small participant target, below the 400-participant average among 11 other Hip Osteoarthritis trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Hip Osteoarthritis appearing as the primary indexed condition, and to 1 intervention - of which Restoration Anatomic Acetabular Shell is the first listed.
NCT05591859 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT05591859 about?
NCT05591859 is a clinical study titled "Restoration Anatomic Acetabular Shell Revision Study". This study will be a non-randomized, ambidirectional (retrospective and prospective) study where all subjects will be followed prospectively. The study will evaluate the survivorship of the RAS acetabular component in a previously failed total hip arthroplasty (THA) in a consecutive series of subjec...
What is the current status of trial NCT05591859?
This trial is currently recruiting. It is a NA study. The enrollment target is 56 participants. The study started on 2024-03-02. Estimated completion is 2036-03-01.
What conditions does trial NCT05591859 study?
This clinical trial studies the following conditions: Hip Osteoarthritis, Hip Arthropathy, Arthropathy.
What interventions are being tested in trial NCT05591859?
The interventions under investigation include: Restoration Anatomic Acetabular Shell (DEVICE).
Who is sponsoring clinical trial NCT05591859?
This trial is sponsored by Stryker Orthopaedics, which has 27 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05591859 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Osteoarthritis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05591859's enrollment target sits among peer trials
56 11th of 11 higher than 1 of 11 other Hip Osteoarthritis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hip Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
General vs Spinal in Total Joint Arthroplasty (TJA)
RECRUITING · NA
-
Positioning for Hip Arthroscopic Surgery to Reduce Postoperative Numbness
RECRUITING · NA
-
Influence of Antiseptic Washes on Wound Healing Complications After THA
RECRUITING · NA
-
Insignia™ Hip Stem Outcomes Study
ACTIVE NOT RECRUITING · NA
-
Shared Decision Making in Patients With Osteoarthritis of the Hip and Knee
COMPLETED · NA
-
Physical Therapy Following Total Hip Arthroplasty
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI